Sheng Hou

2.3k total citations
73 papers, 1.8k citations indexed

About

Sheng Hou is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Sheng Hou has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Radiology, Nuclear Medicine and Imaging, 33 papers in Immunology and 29 papers in Molecular Biology. Recurrent topics in Sheng Hou's work include Monoclonal and Polyclonal Antibodies Research (39 papers), Glycosylation and Glycoproteins Research (12 papers) and Immunotherapy and Immune Responses (12 papers). Sheng Hou is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (39 papers), Glycosylation and Glycoproteins Research (12 papers) and Immunotherapy and Immune Responses (12 papers). Sheng Hou collaborates with scholars based in China, United States and Singapore. Sheng Hou's co-authors include Weizhu Qian, Yajun Guo, Jianxin Dai, Bohua Li, Huaizu Guo, Dapeng Zhang, Yajun Guo, Geng Kou, Huafeng Wei and Lei Zhao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Sheng Hou

72 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Hou China 26 798 696 591 533 185 73 1.8k
Ron Israeli United States 20 800 1.0× 340 0.5× 518 0.9× 592 1.1× 110 0.6× 42 2.2k
Bindu Varghese United States 15 419 0.5× 1.4k 2.0× 249 0.4× 675 1.3× 107 0.6× 25 2.1k
Birgit M. Reipert Austria 25 827 1.0× 562 0.8× 420 0.7× 429 0.8× 53 0.3× 91 2.7k
Takami Matsuyama Japan 24 530 0.7× 1.3k 1.9× 158 0.3× 439 0.8× 301 1.6× 51 2.2k
An Song United States 20 1.1k 1.3× 610 0.9× 684 1.2× 381 0.7× 56 0.3× 39 1.8k
Philip M. Wallace United States 24 787 1.0× 1.2k 1.7× 567 1.0× 532 1.0× 57 0.3× 36 2.3k
Vincent Castronovo Belgium 21 930 1.2× 343 0.5× 418 0.7× 1.1k 2.1× 258 1.4× 28 2.3k
Steinar Funderud Norway 26 787 1.0× 660 0.9× 274 0.5× 317 0.6× 55 0.3× 47 1.7k
Ido D. Weiss United States 30 568 0.7× 1.0k 1.4× 354 0.6× 977 1.8× 54 0.3× 48 2.3k
Zoë Johnson Switzerland 19 1000 1.3× 1.2k 1.7× 187 0.3× 1.2k 2.3× 77 0.4× 43 2.6k

Countries citing papers authored by Sheng Hou

Since Specialization
Citations

This map shows the geographic impact of Sheng Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Hou more than expected).

Fields of papers citing papers by Sheng Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Hou. The network helps show where Sheng Hou may publish in the future.

Co-authorship network of co-authors of Sheng Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Hou. A scholar is included among the top collaborators of Sheng Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Hou. Sheng Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Dapeng, Ting Gao, Qingcheng Guo, et al.. (2025). Rapid and sensitive Mycoplasma detection in antibody bioprocessing via RPA-CRISPR/Cas12a. Journal of Pharmaceutical and Biomedical Analysis. 263. 116904–116904.
2.
Liu, Boning, Huaizu Guo, Jin Xu, et al.. (2016). Acid-induced aggregation propensity of nivolumab is dependent on the Fc. mAbs. 8(6). 1107–1117. 40 indexed citations
3.
Jiang, Cheng, Zhenhua Li, Shengyu Wang, et al.. (2016). Regulation of cell growth and apoptosis through lactate dehydrogenase C over-expression in Chinese hamster ovary cells. Applied Microbiology and Biotechnology. 100(11). 5007–5016. 27 indexed citations
4.
5.
Liang, Shuaiyi, Jianxin Dai, Sheng Hou, et al.. (2013). Structural Basis for Treating Tumor Necrosis Factor α (TNFα)-associated Diseases with the Therapeutic Antibody Infliximab. Journal of Biological Chemistry. 288(19). 13799–13807. 85 indexed citations
6.
Li, Bohua, Yanchun Meng, Lei Zheng, et al.. (2013). Bispecific Antibody to ErbB2 Overcomes Trastuzumab Resistance through Comprehensive Blockade of ErbB2 Heterodimerization. Cancer Research. 73(21). 6471–6483. 47 indexed citations
7.
8.
Yang, Haiou, Huaizu Guo, Kexing Fan, et al.. (2011). Clearance of Propionibacterium acnes by kupffer cells is regulated by osteopontin through modulating the expression of p47phox. Molecular Immunology. 48(15-16). 2019–2026. 8 indexed citations
9.
10.
Lu, Bin, Huaizu Guo, Jian Zhao, et al.. (2010). Increased Expression of iASPP, Regulated by Hepatitis B Virus X Protein-Mediated NF-κB Activation, in Hepatocellular Carcinoma. Gastroenterology. 139(6). 2183–2194.e5. 41 indexed citations
11.
Wang, Hao, Huafeng Wei, Ruiping Zhang, et al.. (2009). Genetically Targeted T Cells Eradicate Established Breast Cancer in Syngeneic Mice. Clinical Cancer Research. 15(3). 943–950. 10 indexed citations
12.
Gao, Jie, Bohua Li, Huimei Li, et al.. (2009). Development and characterization of a fully functional small anti-HER2 antibody. BMB Reports. 42(10). 636–641. 3 indexed citations
13.
Dai, Jianxin, Bohua Li, Jinping Shi, et al.. (2009). A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo. Cancer Immunology Immunotherapy. 59(3). 355–366. 47 indexed citations
14.
Wei, Huafeng, Hao Wang, Bohua Li, et al.. (2008). Cancer Immunotherapy Using In vitro Genetically Modified Targeted Dendritic Cells. Cancer Research. 68(10). 3854–3862. 19 indexed citations
15.
Gao, Jie, Geng Kou, Huaiwen Chen, et al.. (2008). Treatment of hepatocellular carcinoma in mice with PE38KDEL type I mutant-loaded poly(lactic-co-glycolic acid) nanoparticles conjugated with humanized SM5-1 F(ab′) fragments. Molecular Cancer Therapeutics. 7(10). 3399–3407. 19 indexed citations
16.
Qian, Weizhu, Ling Wang, Bohua Li, et al.. (2008). Development of new versions of anti-human CD34 monoclonal antibodies with potentially reduced immunogenicity. Biochemical and Biophysical Research Communications. 367(2). 497–502. 6 indexed citations
17.
Lu, Cheng, Aito Ueno, Jin S. Im, et al.. (2007). Efficient Activation of Vα14 Invariant NKT Cells by Foreign Lipid Antigen Is Associated with Concurrent Dendritic Cell-Specific Self Recognition. The Journal of Immunology. 178(5). 2755–2762. 14 indexed citations
18.
Dai, Jianxin, Jun Jin, Bohua Li, et al.. (2007). A chimeric SM5-1 antibody inhibits hepatocellular carcinoma cell growth and induces caspase-dependent apoptosis. Cancer Letters. 258(2). 208–214. 7 indexed citations
19.
Wei, Huafeng, Hao Wang, Sheng Hou, et al.. (2006). DRB Genotyping in Cynomolgus Monkeys from China Using Polymerase Chain Reaction -Sequence-Specific Primers. Human Immunology. 68(2). 135–144. 9 indexed citations
20.
Lui, Louis Tak, et al.. (1998). Irradiation or temporal variations in immunosuppressive schedules do not prevent graft-versus-host disease following rat limb allotransplantation. Transplantation Proceedings. 30(8). 3960–3961. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ron Israeli Breakdown of academic impact, for papers by Bindu Varghese Breakdown of academic impact, for papers by Birgit M. Reipert Breakdown of academic impact, for papers by Takami Matsuyama Breakdown of academic impact, for papers by An Song Breakdown of academic impact, for papers by Philip M. Wallace Breakdown of academic impact, for papers by Vincent Castronovo Breakdown of academic impact, for papers by Steinar Funderud Breakdown of academic impact, for papers by Ido D. Weiss Breakdown of academic impact, for papers by Zoë Johnson
Rankless by CCL
2026